Cargando…

Class C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cells

The aim of the present study was to investigate whether class C1 decoy oligodeoxynucleotides (ODNs) can inhibit the expression of pro-fibrotic genes associated with rat hepatic stellate cell (HSC) activation and hepatic fibrosis. Luciferase reporter assays were performed to test the promoter activit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Chun, Ni, Yi-Ran, Zhao, Yan-Min, Zhang, Yan-Qiong, Zhou, Rui-Ting, Liu, Chang-Bai, Han, Lin, Wu, Jiang-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947877/ https://www.ncbi.nlm.nih.gov/pubmed/31974596 http://dx.doi.org/10.3892/mmr.2019.10881

Ejemplares similares

SP1 and UTE1 Decoy ODNs inhibit activation and proliferation of hepatic stellate cells by targeting tissue inhibitors of metalloproteinase 1
por: Jia, Dong, et al.
Publicado: (2016)

Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice
por: He, Fei, et al.
Publicado: (2022)

STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants
por: Stojanovic, Tomislav, et al.
Publicado: (2009)

Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia
por: An, Hyun-Jin, et al.
Publicado: (2020)

Ultrasound microbubble-mediated transfection of NF-κB decoy oligodeoxynucleotide into gingival tissues inhibits periodontitis in rats in vivo
por: Yamaguchi, Hiroyuki, et al.
Publicado: (2017)

Antifibrotic Effect of Smad Decoy Oligodeoxynucleotide in a CCl(4)-Induced Hepatic Fibrosis Animal Model
por: Gwon, Mi-Gyeong, et al.
Publicado: (2018)

ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy
por: Lin, Minghua, et al.
Publicado: (2017)

Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs)
por: Wang, Zhipeng, et al.
Publicado: (2018)

Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
por: Lee, David S., et al.
Publicado: (2018)

Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial–Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis
por: Yan, Mengli, et al.
Publicado: (2023)

Amelioration of collagen-induced arthritis using antigen-loaded dendritic cells modified with NF-κB decoy oligodeoxynucleotides
por: Jiang, Hongmei, et al.
Publicado: (2017)

Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
por: Zhang, Xulong, et al.
Publicado: (2007)

NF-κB Decoy Oligodeoxynucleotide-Coated Balloon Catheter for Arteriovenous Fistula in Hemodialysis
por: Fukasawa, Mizuya, et al.
Publicado: (2018)

Hydrostatic pressure induces profibrotic properties in hepatic stellate cells via the RhoA/ROCK signaling pathway
por: Huang, Zisheng, et al.
Publicado: (2022)

Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of TGF-β/SMAD signaling and autophagy in hepatic stellate cells
por: Kanmani, Paulraj, et al.
Publicado: (2022)

Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis
por: Wee, Jee Hye, et al.
Publicado: (2017)

STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells
por: Ma, Yanhui, et al.
Publicado: (2015)

Influence of pentylenetetrazol and NF-κB decoy oligodeoxynucleotides on p38 expression in neuron-like cells
por: YANG, JIA-JUN, et al.
Publicado: (2014)

Effect of STAT3 decoy oligodeoxynucleotides mediated by ultrasound-targeted microbubbles combined with ultrasound on the growth of squamous cell carcinoma of the esophagus
por: Zhang, Yan, et al.
Publicado: (2019)

Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1)
por: Hückel, Marion, et al.
Publicado: (2006)

Inhibitory effect of ribbon-type NF-κB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo
por: Kunugiza, Yasuo, et al.
Publicado: (2006)

Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides
por: Farahmand, Leila, et al.
Publicado: (2017)

DNA minicircles as novel STAT3 decoy oligodeoxynucleotides endowed with anticancer activity in triple-negative breast cancer
por: Casas, Geoffrey, et al.
Publicado: (2022)

The decoy oligodeoxynucleotide against HIF-1α and STAT5 ameliorates atopic dermatitis-like mouse model
por: Gwon, Mi-Gyeong, et al.
Publicado: (2023)

Hepatocyte-Specific Triggering of Hepatic Stellate Cell Profibrotic Activation by Apoptotic Bodies: The Role of Hepatoma-Derived Growth Factor, HIV, and Ethanol
por: New-Aaron, Moses, et al.
Publicado: (2023)

A new approach to transfect NF-κB decoy oligodeoxynucleotides into the periodontal tissue using the ultrasound-microbubble method
por: Yamaguchi, Hiroyuki, et al.
Publicado: (2017)

The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells
por: Wan, Lin-Yan, et al.
Publicado: (2022)

Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis
por: Imbaby, Samar, et al.
Publicado: (2020)

The Effects of Synthetic SREBP-1 and PPAR-γ Decoy Oligodeoxynucleotide on Acne-like Disease In Vivo and In Vitro via Lipogenic Regulation
por: Gu, Hyemin, et al.
Publicado: (2022)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

STAT3/NF-κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF-κB signaling pathway in a mouse model of atherosclerosis
por: An, Hyun-Jin, et al.
Publicado: (2023)

Suppression of hepatic stellate cell activation through downregulation of gremlin1 expression by the miR-23b/27b cluster
por: Zeng, Xian-Yi, et al.
Publicado: (2016)

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer
por: Teranishi, Shuhei, et al.
Publicado: (2020)

Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice
por: Li, Yu-Tao, et al.
Publicado: (2009)

Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10
por: Wang, Ya-Hui, et al.
Publicado: (2017)

Class II HDAC Inhibition Hampers Hepatic Stellate Cell Activation by Induction of MicroRNA-29
por: Mannaerts, Inge, et al.
Publicado: (2013)

Inhibition of profibrotic microRNA-21 affects platelets and their releasate
por: Barwari, Temo, et al.
Publicado: (2018)

Transfection of Vein Grafts with Early Growth Response Factor-1 Oligodeoxynucleotide Decoy: Effects on Stem-Cell Genes and Toll-like Receptor-Mediated Inflammation
por: Mylonas, Konstantinos S., et al.
Publicado: (2023)

Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation
por: Wang, Yun, et al.
Publicado: (2019)

Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
por: Chong, Lee-Won, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o6c62uk0ahmmljvi0k1tcdghis